Introduction
- What are the main objectives of the cardiovascular outcomes trials (CVOT) for type 2 diabetes (T2D) therapeutics?
- Over the past 7 years, what have the outcomes of major CVOTs for T2D therapeutics shown?
- Which drug classes have demonstrated the greatest cardiovascular benefits?
- How have diabetes guidelines changed in response to results of CVOT trials?